AstraZeneca Pharma launches anti-diabetic tablet Xigduo XR
Xigduo XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Bengaluru hosts India Pharma 2018 and India Medical Device 2018 conference
Over 20 international drug and device regulators are set to meet with Indian regulators at the venue
Union minister of Chemicals…
Queen’s University announces NDDS to reduce HIV rate
The university along with their collaborators, PATH, ViiV Healthcare, the Population Council and LTS Lohmann Therapie-Systeme will…
Govt to bring major changes in DPCO: Union Minister Ananth Kumar
Reiterates the need for a separate Ministry for Pharma and Medical Devices
GNH India clears Oman Pharmacy and Poison board audit
The audit will give preferential status to GNH India in the Oman trade market over other suppliers from countries including the US…
Sundyota Numandis in strategic alliance with Finzelberg
To exclusively represent the German phyto-pharmaceuticals major in India
Sun Pharma posts Q3FY18 results
Q3 adjusted net profit was at Rs 878 crores
Sun Pharmaceutical Industries has posted third quarter and nine month financial…
CMFRI to launch marine nutraceutical product to treat thyroid disorders
According to Dr A Gopalakrishnan, Director, CMFRI, the product will be commercialised soon after the successful completion of the…
OPTEL Group acquires GeoTraceability
The acquisition will allow OPTEL to close its end-to-end traceability loop, by completing its offer with the first link in the…
US advocacy group wants USTR to put India on priority watch list
AFTI alleges that Delhi did not address numerous critical and long standing shortcomings to its IPR regime